MarkSKipnesMD

Clinical Trials

• Patient Preference of h-Patch vs. Pen or Needle/Syringe as Insulin Administration Device Start of enrollment: 2007 May 01

  Terminated

  Phase 4

• Study of Atorvastatin/Fenofibrate (LCP-AtorFen) Combination Therapy in Dyslipidemia Start of enrollment: 2007 Jul 01

  Completed

  Phase 2

• A Single Dose, Tolerance and Pharmacokinetic Study in Obese or Overweight Type 2 Diabetic Volunteers Start of enrollment: 2008 Jan 01

  Completed

  Phase 1

• 12-Month, Open-Label, Extension Study of LCP-AtorFen in Dyslipidemia Start of enrollment: 2007 Oct 01

  Completed

  Phase 2, Phase 3

• A Study to Determine the Effects of TM30339 on Weight Loss in Obese Individuals. Start of enrollment: 2008 Aug 01

  Terminated

  Phase 2

• An Ascending Multi-Dose, Tolerance and Pharmacokinetic Study in Obese or Overweight Type 2 Diabetic Volunteers Start of enrollment: 2008 Nov 01

  Completed

  Phase 1

• Pilot Study Assessing Insulin Pump Therapy in Type 2 Diabetes Start of enrollment: 2008 Feb 01

  Completed

  Not Applicable

• Glycemic Control and Treatment Satisfaction Using Finesse Versus Pen for Initiating Bolus Insulin Dosing in Type 2 Diabetes Patients Start of enrollment: 2015 Aug 01

  Completed

  Not Applicable

• Exploratory Study of the Efficacy of Standard of Care Revascularization of the Lower Extremity Start of enrollment: 2021 Feb 15

  Not yet recruiting

  Not Applicable

• Omnipod 5 System Compared to Pump Therapy Start of enrollment: 2022 Jul 07

  Active, not recruiting

  Not Applicable

  Roles: Contact

• A Phase III Study to Investigate if the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed With Type 1 Diabetes Start of enrollment: 2022 May 19

  Recruiting

  Phase 3

  Roles: Contact

• Join now to see all